Ulisse Biomed S.p.A.
$0.81▲ 0.00%(+$0.00)
TickerSpark Score
43/100
▌ Weak
20
Valuation
20
Profitability
100
Growth
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UBM.MI research report →
52-Week Range18% of range
Low
$0.68
Current
$0.81
High
$1.40
Company Overviewwww.ulissebiomed.com
About the company
Ulisse Biomed S. p. A.
- CEO
- Nicola Basile
- IPO
- 2021
- Employees
- 8
- HQ
- Udine, UD, IT
Price Chart
-17.45% · this period
Growth & Income
- Revenue
- $407.79K · 515.92%
- Net Income
- $-1,462,928 · 69.50%
- EPS
- $-0.06 · 72.09%
- Op Income
- $-1,449,853
- FCF YoY
- -3.98%
Performance & Tape
- 52W High
- $1.40
- 52W Low
- $0.68
- 50D MA
- $0.90
- 200D MA
- $0.85
- Beta
- 0.80
- Avg Volume
- 119.44K
Get TickerSpark's AI analysis on UBM.MI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · UBM.MI
Our UBM.MI coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on UBM.MI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UBM.MI report →Internal Compare
Similar companies
Peers in the same neighborhood.